Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Breast implant litigation

This article was originally published in The Gray Sheet

Executive Summary

Breast implant litigation: Louisiana state court in New Orleans postpones until Jan. 7 Phase II of the first class action silicone breast implant trial against Dow Chemical while the federal Sixth Circuit Court of Appeals in Cincinnati decides on a writ of mandamus submitted last summer by Dow. The writ seeks reversal of a ruling by Eastern Michigan District Court Judge Denise Hood to allow eight cases in Louisiana to be completed in that state while the remaining 1,792 pending cases against Dow Corning shareholders Dow Chemical and Corning are transferred to the Michigan court, where all breast implant suits filed against Dow Corning are being examined under bankruptcy proceedings initiated in May 1995. The writ also seeks clarification from the court on whether findings of the Louisiana court can apply to those cases not yet underway in Michigan. A May 8 decision by the Cincinnati appeals court ordered Hood to consolidate in Michigan all outstanding cases against Dow Chemical. On Nov. 10, the U.S. Supreme Court denied a plaintiffs' petition for a writ of certiorari requesting that the high court review the May 8 ruling...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel